EO 14398 IDIQ: chemistry, manufacturing and controls and related services for development of drug substances (trnd 1)
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95026D00009
- Awardee
-
SIA Partners U.s., Inc. UEI ZNN5L5F7BCY9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances Solicitation · 75N95024R00094 · Posted Oct 9, 2024
- Last date to order 5% complete
- IDV ceiling
- $49,713,679.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 11 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded a multiple-award indefinite-delivery contract to SIA Partners U.S., Inc. on August 1, 2026, with a ceiling of $49,713,679 and an ultimate completion date of May 14, 2031.
The contract supports chemistry, manufacturing, and controls (CMC) services for development of drug substances in preclinical and Investigational New Drug (IND)-enabling studies. The original solicitation, posted October 9, 2024 with a December 3, 2024 due date, sought offerors to propose on one or more of three technical areas: small molecules, peptides, and biopharmaceuticals. Evaluation criteria include technical approach, personnel qualifications, facilities, quality management, and organizational experience.
Work is performed in the United States over a seven-year period from September 1, 2025 through May 14, 2031. The contract carries a $1,000 minimum guarantee per IDIQ awardee. This is an unrestricted procurement with no set-aside category.
Quick answers
Who was awarded contract 75N95026D00009?
75N95026D00009 was awarded to SIA Partners U.s., Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2026.
How much is contract 75N95026D00009 worth?
75N95026D00009's own ceiling is $49,713,679.
Who can order from contract 75N95026D00009?
75N95026D00009 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95026D00009 competed?
The extent of competition for 75N95026D00009 was full and open competition. The government received 11 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV